{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:55:19Z","timestamp":1785383719076,"version":"3.55.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100021528","name":"Advancing a Healthier Wisconsin Endowment","doi-asserted-by":"publisher","award":["9520699"],"award-info":[{"award-number":["9520699"]}],"id":[{"id":"10.13039\/100021528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1245\/s10434-024-15701-2","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T13:03:26Z","timestamp":1719579806000},"page":"7474-7482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals: A Pilot Single-Arm Educational Intervention Trial"],"prefix":"10.1245","volume":"31","clinical-trial-number":[{"clinical-trial-number":"nct06239766","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-5028","authenticated-orcid":false,"given":"Chandler S.","family":"Cortina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Purdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Brazauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Stachowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Fodrocy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen A.","family":"Klement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Sasor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate B.","family":"Krucoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Buth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie E. B.","family":"Lakatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Petroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Doren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"15701_CR1","unstructured":"Key findings about LGBTQ+ Americans. Pew Research Center. Published June 23, 2023. https:\/\/www.pewresearch.org\/short-reads\/2023\/06\/23\/5-key-findings-about-lgbtq-americans. Accessed January 30, 2024."},{"key":"15701_CR2","unstructured":"What percentage of the US population is transgender? USA Facts. Published August 3, 2023. https:\/\/usafacts.org\/articles\/what-percentage-of-the-us-population-is-transgender\/#footnote-source-1. Accessed February 1, 2024."},{"issue":"2","key":"15701_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2105\/AJPH.2016.303578","volume":"107","author":"EL Meerwijk","year":"2017","unstructured":"Meerwijk EL, Sevelius JM. Transgender population size in the United States: a meta-regression of population-based probability samples. Am J Public Health. 2017;107(2):e1\u20138. https:\/\/doi.org\/10.2105\/AJPH.2016.303578.","journal-title":"Am J Public Health"},{"issue":"7","key":"15701_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jamasurg.2017.6231","volume":"153","author":"JK Canner","year":"2018","unstructured":"Canner JK, Harfouch O, Kodadek LM, et al. Temporal trends in gender-affirming surgery among transgender patients in the United States. JAMA Surg. 2018;153(7):609\u201316. https:\/\/doi.org\/10.1001\/jamasurg.2017.6231.","journal-title":"JAMA Surg"},{"issue":"8","key":"15701_CR5","doi-asserted-by":"publisher","first-page":"e2330348","DOI":"10.1001\/jamanetworkopen.2023.30348","volume":"6","author":"JD Wright","year":"2023","unstructured":"Wright JD, Chen L, Suzuki Y, Matsuo K, Hershman DL. National estimates of gender-affirming surgery in the US. JAMA Netw Open. 2023;6(8):e2330348. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.30348.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"15701_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.surg.2021.02.013","volume":"170","author":"AA Akhavan","year":"2021","unstructured":"Akhavan AA, Sandhu S, Ndem I, Ogunleye AA. A review of gender affirmation surgery: What we know, and what we need to know. Surgery. 2021;170(1):336\u201340. https:\/\/doi.org\/10.1016\/j.surg.2021.02.013.","journal-title":"Surgery"},{"issue":"4","key":"15701_CR7","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1245\/s10434-021-10217-5","volume":"29","author":"CN Clarke","year":"2022","unstructured":"Clarke CN, Cortina CS, Fayanju OM, Dossett LA, Johnston FM, Wong SL. Breast cancer risk and screening in transgender persons: a call for inclusive care. Ann Surg Oncol. 2022;29(4):2176\u201380. https:\/\/doi.org\/10.1245\/s10434-021-10217-5.","journal-title":"Ann Surg Oncol"},{"issue":"17","key":"15701_CR8","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1001\/jama.2020.22414","volume":"325","author":"I Jatoi","year":"2021","unstructured":"Jatoi I, Kemp Z. Risk-reducing mastectomy. JAMA. 2021;325(17):1781\u20132. https:\/\/doi.org\/10.1001\/jama.2020.22414.","journal-title":"JAMA"},{"issue":"2","key":"15701_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jamasurg.2017.3422","volume":"153","author":"JW Jakub","year":"2018","unstructured":"Jakub JW, Peled AW, Gray RJ, et al. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: a multi-institutional study. JAMA Surg. 2018;153(2):123\u20139. https:\/\/doi.org\/10.1001\/jamasurg.2017.3422.","journal-title":"JAMA Surg"},{"issue":"10","key":"15701_CR10","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1245\/s10434-021-10445-9","volume":"28","author":"M Garstka","year":"2021","unstructured":"Garstka M, Henriquez A, Kelly BN, et al. How protective are nipple-sparing prophylactic mastectomies in BRCA1 and BRCA2 mutation carriers? Ann Surg Oncol. 2021;28(10):5657\u201362. https:\/\/doi.org\/10.1245\/s10434-021-10445-9.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"15701_CR11","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.ejso.2018.06.021","volume":"44","author":"JP Stone","year":"2018","unstructured":"Stone JP, Hartley RL, Temple-Oberle C. Breast cancer in transgender patients: a systematic review. Part 2: female to male. Eur J Surg Oncol. 2018;44(10):1463\u20138. https:\/\/doi.org\/10.1016\/j.ejso.2018.06.021.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"15701_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00545-9","volume":"24","author":"CS Cortina","year":"2023","unstructured":"Cortina CS, Kong AL. Chest mass in a transgender man after top surgery. Lancet Oncol. 2023;24(1):e57. https:\/\/doi.org\/10.1016\/S1470-2045(22)00545-9.","journal-title":"Lancet Oncol"},{"key":"15701_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.breast.2020.06.008","volume":"53","author":"AC Fledderus","year":"2020","unstructured":"Fledderus AC, Gout HA, Ogilvie AC, van Loenen DKG. Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening. Breast. 2020;53:92\u2013100. https:\/\/doi.org\/10.1016\/j.breast.2020.06.008.","journal-title":"Breast"},{"issue":"7","key":"15701_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamasurg.2021.0952","volume":"156","author":"AN Almazan","year":"2021","unstructured":"Almazan AN, Keuroghlian AS. Association between gender-affirming surgeries and mental health outcomes. JAMA Surg. 2021;156(7):611\u20138. https:\/\/doi.org\/10.1001\/jamasurg.2021.0952.","journal-title":"JAMA Surg"},{"issue":"4","key":"15701_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/jamasurg.2022.5447","volume":"158","author":"CS Cortina","year":"2023","unstructured":"Cortina CS. Assessing breast and ovarian cancer risk prior to gender-affirming surgery. JAMA Surg. 2023;158(4):339\u201340. https:\/\/doi.org\/10.1001\/jamasurg.2022.5447.","journal-title":"JAMA Surg"},{"issue":"4","key":"15701_CR16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142029","volume":"131","author":"JD Safer","year":"2021","unstructured":"Safer JD. Research gaps in medical treatment of transgender\/nonbinary people. J Clin Invest. 2021;131(4):e142029. https:\/\/doi.org\/10.1172\/JCI142029.","journal-title":"J Clin Invest"},{"issue":"8","key":"15701_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/jamaoncol.2022.1638","volume":"8","author":"CS Cortina","year":"2022","unstructured":"Cortina CS. Inclusion and reporting of transgender and nonbinary persons in clinical trials and tumor registries-the time is now. JAMA Oncol. 2022;8(8):1097\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2022.1638.","journal-title":"JAMA Oncol"},{"issue":"1","key":"15701_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"15701_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","volume":"93","author":"B Rockhill","year":"2001","unstructured":"Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. JNCI J Natl Cancer Inst. 2001;93(5):358\u201366. https:\/\/doi.org\/10.1093\/jnci\/93.5.358.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"1","key":"15701_CR20","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/bcr3104","volume":"14","author":"WY Chay","year":"2012","unstructured":"Chay WY, Ong WS, Tan PH, et al. Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women. Breast Cancer Res. 2012;14(1):R19. https:\/\/doi.org\/10.1186\/bcr3104.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"15701_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13058-018-1084-x","volume":"20","author":"C Nickson","year":"2018","unstructured":"Nickson C, Procopio P, Velentzis LS, et al. Prospective validation of the NCI breast cancer risk assessment tool (Gail Model) on 40,000 Australian women. Breast Cancer Res. 2018;20(1):155. https:\/\/doi.org\/10.1186\/s13058-018-1084-x.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"15701_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/jnci\/djq141","volume":"102","author":"MH Gail","year":"2010","unstructured":"Gail MH, Mai PL. Comparing breast cancer risk assessment models. J Natl Cancer Inst. 2010;102(10):665\u20138. https:\/\/doi.org\/10.1093\/jnci\/djq141.","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"15701_CR23","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1002\/cncr.33767","volume":"127","author":"AW Kurian","year":"2021","unstructured":"Kurian AW, Hughes E, Simmons T, et al. Performance of the IBIS\/Tyrer\u2013Cuzick model of breast cancer risk by race and ethnicity in the Women\u2019s Health Initiative. Cancer. 2021;127(20):3742\u201350. https:\/\/doi.org\/10.1002\/cncr.33767.","journal-title":"Cancer"},{"key":"15701_CR24","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00484","author":"S Gallagher","year":"2021","unstructured":"Gallagher S, Hughes E, Kurian AW, et al. Comprehensive breast cancer risk assessment for CHEK2 and ATM pathogenic variant carriers incorporating a polygenic risk score and the Tyrer\u2013Cuzick model. JCO Precis Oncol. 2021. https:\/\/doi.org\/10.1200\/PO.20.00484.","journal-title":"JCO Precis Oncol"},{"issue":"11","key":"15701_CR25","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.31557\/APJCP.2019.20.11.3407","volume":"20","author":"KP Stevanato","year":"2019","unstructured":"Stevanato KP, Pedroso RB, Iora P, et al. Comparative analysis between the Gail, Tyrer\u2013Cuzick and BRCAPRO models for breast cancer screening in Brazilian population. Asian Pac J Cancer Prev. 2019;20(11):3407\u201313. https:\/\/doi.org\/10.31557\/APJCP.2019.20.11.3407.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"15701_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1214\/19-STS729","volume":"35","author":"AR Brentnall","year":"2020","unstructured":"Brentnall AR, Cuzick J. Risk models for breast cancer and their validation. Stat Sci. 2020;35(1):14\u201330. https:\/\/doi.org\/10.1214\/19-STS729.","journal-title":"Stat Sci"},{"key":"15701_CR27","unstructured":"Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. London: National Institute for Health and Care Excellence (NICE); November 2019."},{"issue":"19","key":"15701_CR28","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1200\/JCO.18.01779","volume":"37","author":"A DeCensi","year":"2019","unstructured":"DeCensi A, Puntoni M, Guerrieri-Gonzaga A, et al. Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia. J Clin Oncol. 2019;37(19):1629\u201337. https:\/\/doi.org\/10.1200\/JCO.18.01779.","journal-title":"J Clin Oncol"},{"issue":"3","key":"15701_CR29","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jacr.2017.11.034","volume":"15","author":"DL Monticciolo","year":"2018","unstructured":"Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA. Breast cancer screening in women at\u00a0higher-than-average risk: recommendations from the ACR. J Am Coll Radiol. 2018;15(3):408\u201314. https:\/\/doi.org\/10.1016\/j.jacr.2017.11.034.","journal-title":"J Am Coll Radiol"},{"issue":"11","key":"15701_CR30","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s11547-016-0667-9","volume":"121","author":"G Mariscotti","year":"2016","unstructured":"Mariscotti G, Belli P, Bernardi D, et al. Mammography and MRI for screening women who underwent chest radiation therapy (lymphoma survivors): recommendations for surveillance from the Italian College of Breast Radiologists by SIRM. Radiol Med. 2016;121(11):834\u20137. https:\/\/doi.org\/10.1007\/s11547-016-0667-9.","journal-title":"Radiol Med."},{"issue":"10","key":"15701_CR31","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1080\/17512433.2016.1231575","volume":"9","author":"N Provinciali","year":"2016","unstructured":"Provinciali N, Suen C, Dunn BK, DeCensi A. Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women. Expert Rev Clin Pharmacol. 2016;9(10):1263\u201372. https:\/\/doi.org\/10.1080\/17512433.2016.1231575.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"15701_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10549-019-05345-2","volume":"177","author":"BAM Heemskerk-Gerritsen","year":"2019","unstructured":"Heemskerk-Gerritsen BAM, Jager A, Koppert LB, et al. Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2019;177(3):723\u201333. https:\/\/doi.org\/10.1007\/s10549-019-05345-2.","journal-title":"Breast Cancer Res Treat"},{"issue":"18","key":"15701_CR33","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1200\/JCO.20.00299","volume":"38","author":"NM Tung","year":"2020","unstructured":"Tung NM, Boughey JC, Pierce LJ, et al. Management of hereditary breast cancer: American society of clinical oncology, american society for radiation oncology, and society of surgical oncology guideline. J Clin Oncol. 2020;38(18):2080\u2013106. https:\/\/doi.org\/10.1200\/JCO.20.00299.","journal-title":"J Clin Oncol"},{"issue":"10","key":"15701_CR34","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","volume":"26","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M, et al. Consensus guidelines on genetic testing for hereditary breast cancer from the American Society of Breast Surgeons. Ann Surg Oncol. 2019;26(10):3025\u201331. https:\/\/doi.org\/10.1245\/s10434-019-07549-8.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"15701_CR35","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967\u201375. https:\/\/doi.org\/10.1001\/jama.2010.1237.","journal-title":"JAMA"},{"key":"15701_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.18.00072","volume":"3","author":"X Jiang","year":"2019","unstructured":"Jiang X, McGuinness JE, Sin M, Silverman T, Kukafka R, Crew KD. Identifying women at high risk for breast cancer using data from the electronic health record compared with self-report. JCO Clin Cancer Inform. 2019;3:1\u20138. https:\/\/doi.org\/10.1200\/CCI.18.00072.","journal-title":"JCO Clin Cancer Inform"},{"issue":"1","key":"15701_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12905-021-01238-z","volume":"21","author":"K Hajian-Tilaki","year":"2021","unstructured":"Hajian-Tilaki K, Nikpour M. Accuracy of self-perceived risk perception of breast cancer development in Iranian women. BMC Womens Health. 2021;21(1):93. https:\/\/doi.org\/10.1186\/s12905-021-01238-z.","journal-title":"BMC Womens Health"},{"issue":"2","key":"15701_CR38","first-page":"122","volume":"1","author":"ET de Jonge","year":"2009","unstructured":"de Jonge ET, Vlasselaer J, Van de Putte G, Schobbens JC. The construct of breast cancer risk perception: need for a better risk communication? Facts Views Vis Obgyn. 2009;1(2):122\u20139.","journal-title":"Facts Views Vis Obgyn"},{"issue":"5","key":"15701_CR39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1089\/jwh.2013.4516","volume":"23","author":"J Fehniger","year":"2014","unstructured":"Fehniger J, Livaudais-Toman J, Karliner L, et al. Perceived versus objective breast cancer risk in diverse women. J Womens Health (Larchmt). 2014;23(5):420\u20137. https:\/\/doi.org\/10.1089\/jwh.2013.4516.","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"15701_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","volume":"19","author":"MB Daly","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, et al. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(1):77\u2013102. https:\/\/doi.org\/10.6004\/jnccn.2021.0001.","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"15701_CR41","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","volume":"26","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M, et al. Consensus guidelines on genetic testing for hereditary breast cancer from the American Society of Breast Surgeons. Ann Surg Oncol. 2019;26(10):3025\u201331. https:\/\/doi.org\/10.1245\/s10434-019-07549-8.","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"15701_CR42","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402\u201316. https:\/\/doi.org\/10.1001\/jama.2017.7112.","journal-title":"JAMA"},{"issue":"2","key":"15701_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10689-016-9869-5","volume":"15","author":"G Corso","year":"2016","unstructured":"Corso G, Intra M, Trentin C, Veronesi P, Galimberti V. CDH1 germline mutations and hereditary lobular breast cancer. Fam Cancer. 2016;15(2):215\u20139. https:\/\/doi.org\/10.1007\/s10689-016-9869-5.","journal-title":"Fam Cancer"},{"issue":"2","key":"15701_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10549-020-05699-y","volume":"182","author":"D Cragun","year":"2020","unstructured":"Cragun D, Weidner A, Tezak A, Clouse K, Pal T. Cancer risk management among female BRCA1\/2, PALB2, CHEK2, and ATM carriers. Breast Cancer Res Treat. 2020;182(2):421\u20138. https:\/\/doi.org\/10.1007\/s10549-020-05699-y.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"15701_CR45","doi-asserted-by":"publisher","first-page":"CD002748","DOI":"10.1002\/14651858.CD002748.pub4","volume":"4","author":"NE Carbine","year":"2018","unstructured":"Carbine NE, Lostumbo L, Wallace J, Ko H. Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database Syst Rev. 2018;4(4):CD002748. https:\/\/doi.org\/10.1002\/14651858.CD002748.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"15701_CR46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371(6):497\u2013506. https:\/\/doi.org\/10.1056\/NEJMoa1400382.","journal-title":"N Engl J Med"},{"issue":"5","key":"15701_CR47","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1200\/OP.22.00681","volume":"19","author":"D Roznovjak","year":"2023","unstructured":"Roznovjak D, Petroll AE, Lakatos AEB, Narayan R, Cortina CS. Perceptions of transgender and nonbinary persons toward breast and cervical cancer development, screening, and potential impact on gender-affirming hormone therapy. JCO Oncol Pract. 2023;19(5):e794\u2013800. https:\/\/doi.org\/10.1200\/OP.22.00681.","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"15701_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12609-020-00403-x","volume":"13","author":"D Roznovjak","year":"2021","unstructured":"Roznovjak D, Petroll AE, Cortina CS. Breast cancer risk and screening in transgender individuals. Curr Breast Cancer Rep. 2021;13(1):56\u201361. https:\/\/doi.org\/10.1007\/s12609-020-00403-x.","journal-title":"Curr Breast Cancer Rep"},{"issue":"3","key":"15701_CR49","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1245\/s10434-021-10932-z","volume":"29","author":"N Luehmann","year":"2022","unstructured":"Luehmann N, Ascha M, Chwa E, et al. A Single-center study of adherence to breast cancer screening mammography guidelines by transgender and non-binary patients. Ann Surg Oncol. 2022;29(3):1707\u201317. https:\/\/doi.org\/10.1245\/s10434-021-10932-z.","journal-title":"Ann Surg Oncol"},{"key":"15701_CR50","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1158\/1055-9965.EPI-22-0393","volume":"31","author":"ML Canet","year":"2022","unstructured":"Canet ML, Harbron R, Thierry-Chef I, Cardis E. Cancer effects of low to moderate doses of ionising radiation in young people with cancer predisposing conditions: a systematic review. Cancer Epidemiol Biomarkers Prev. 2022;31:1871\u201389. https:\/\/doi.org\/10.1158\/1055-9965.EPI-22-0393.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"15701_CR51","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0174","volume":"4","author":"AR Brentnall","year":"2018","unstructured":"Brentnall AR, Cuzick J, Buist DSM, Bowles EJA. Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density. JAMA Oncol. 2018;4(9):e180174. https:\/\/doi.org\/10.1001\/jamaoncol.2018.0174.","journal-title":"JAMA Oncol"},{"issue":"6","key":"15701_CR52","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004;22(6):1055\u201362. https:\/\/doi.org\/10.1200\/JCO.2004.04.188.","journal-title":"J Clin Oncol"},{"key":"15701_CR53","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2012.32.220","author":"CI Flowers","year":"2012","unstructured":"Flowers CI, Mooney BP, Drukteinis JS. Clinical and imaging surveillance following breast cancer diagnosis. Am Soc Clin Oncol Educ Book. 2012. https:\/\/doi.org\/10.14694\/EdBook_AM.2012.32.220.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"15701_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/caac.21319","volume":"66","author":"CD Runowicz","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL, et al. American cancer society\/American society of clinical oncology breast cancer survivorship care guideline. CA Cancer J Clin. 2016;66(1):43\u201373. https:\/\/doi.org\/10.3322\/caac.21319.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"15701_CR55","doi-asserted-by":"publisher","first-page":"e2244212","DOI":"10.1001\/jamanetworkopen.2022.44212","volume":"5","author":"D Smith","year":"2022","unstructured":"Smith D, Sepehr S, Karakatsanis A, Strand F, Valachis A. Yield of surveillance imaging after mastectomy with or without reconstruction for patients with prior breast cancer: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(12):e2244212. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.44212.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"15701_CR56","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijrobp.2018.05.023","volume":"102","author":"DG Giannotti","year":"2018","unstructured":"Giannotti DG, Hanna SA, Cerri GG, Barbosa Bevilacqua JL. Analysis of skin flap thickness and residual breast tissue after mastectomy. Int J Radiat Oncol Biol Phys. 2018;102(1):82\u201391. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.05.023.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"15701_CR57","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1245\/s10434-020-08516-4c","volume":"27","author":"O Kaidar-Person","year":"2020","unstructured":"Kaidar-Person O, Boersma LJ, Poortmans P, et al. Residual glandular breast tissue after mastectomy: a systematic review. Ann Surg Oncol. 2020;27(7):2288\u201396. https:\/\/doi.org\/10.1245\/s10434-020-08516-4c.","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"15701_CR58","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1245\/s10434-022-12418-y","volume":"29","author":"EO Martinez","year":"2022","unstructured":"Martinez EO, Rubin M, Miller T, Cortina CS. Transgender and non-binary persons in contemporary oncology randomized clinical trials. Ann Surg Oncol. 2022;29(13):7958\u201360. https:\/\/doi.org\/10.1245\/s10434-022-12418-y.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"15701_CR59","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/his.13299","volume":"71","author":"EG East","year":"2017","unstructured":"East EG, Gast KM, Kuzon WM Jr, Roberts E, Zhao L, Jorns JM. Clinicopathological findings in female-to-male gender-affirming breast surgery. Histopathology. 2017;71(6):859\u201365. https:\/\/doi.org\/10.1111\/his.13299.","journal-title":"Histopathology"},{"issue":"7","key":"15701_CR60","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/bjs.10794","volume":"105","author":"SMJ Van Renterghem","year":"2018","unstructured":"Van Renterghem SMJ, Van Dorpe J, Monstrey SJ, et al. Routine histopathological examination after female-to-male gender-confirming mastectomy. Br J Surg. 2018;105(7):885\u201392. https:\/\/doi.org\/10.1002\/bjs.10794.","journal-title":"Br J Surg"},{"issue":"1","key":"15701_CR61","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41379-020-00675-9","volume":"34","author":"GM Baker","year":"2021","unstructured":"Baker GM, Guzman-Arocho YD, Bret-Mounet VC, et al. Testosterone therapy and breast histopathological features in transgender individuals. Mod Pathol. 2021;34(1):85\u201394. https:\/\/doi.org\/10.1038\/s41379-020-00675-9.","journal-title":"Mod Pathol"},{"issue":"4 Suppl 4","key":"15701_CR62","doi-asserted-by":"publisher","first-page":"S332","DOI":"10.1097\/SAP.0000000000003083","volume":"88","author":"N Parmeshwar","year":"2022","unstructured":"Parmeshwar N, Song S, Alcon A, Kim EA. The incidence of breast cancer after gender-affirming mastectomy in transmen. Ann Plast Surg. 2022;88(4 Suppl 4):S332\u20136. https:\/\/doi.org\/10.1097\/SAP.0000000000003083.","journal-title":"Ann Plast Surg"},{"issue":"3","key":"15701_CR63","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1245\/s10434-019-07814-w","volume":"27","author":"MG Valero","year":"2020","unstructured":"Valero MG, Zabor EC, Park A, et al. The Tyrer\u2013Cuzick model inaccurately predicts invasive breast cancer risk in women with LCIS. Ann Surg Oncol. 2020;27(3):736\u201340. https:\/\/doi.org\/10.1245\/s10434-019-07814-w.","journal-title":"Ann Surg Oncol"},{"issue":"33","key":"15701_CR64","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","volume":"33","author":"TA King","year":"2015","unstructured":"King TA, Pilewskie M, Muhsen S, et al. Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk. J Clin Oncol. 2015;33(33):3945\u201352. https:\/\/doi.org\/10.1200\/JCO.2015.61.4743.","journal-title":"J Clin Oncol"},{"issue":"3","key":"15701_CR65","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/tbj.13237","volume":"25","author":"KA Klement","year":"2019","unstructured":"Klement KA, Hijjawi JB, Neuner J, Kelley K, Kong AL. Discussion of preoperative mammography in women undergoing reduction mammaplasty. Breast J. 2019;25(3):439\u201343. https:\/\/doi.org\/10.1111\/tbj.13237.","journal-title":"Breast J"},{"issue":"12","key":"15701_CR66","doi-asserted-by":"publisher","first-page":"6978","DOI":"10.1245\/s10434-023-14195-8","volume":"30","author":"CS Cortina","year":"2023","unstructured":"Cortina CS, Siegel EL, Polovneff A, et al. Current insurance policy coverage for screening mammography in transgender and gender-diverse individuals. Ann Surg Oncol. 2023;30(12):6978\u201380. https:\/\/doi.org\/10.1245\/s10434-023-14195-8.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"15701_CR67","doi-asserted-by":"publisher","first-page":"731e","DOI":"10.1097\/PRS.0000000000007883","volume":"147","author":"A Alcon","year":"2021","unstructured":"Alcon A, Kennedy A, Wang E, et al. Quantifying the psychosocial benefits of masculinizing mastectomy in trans male patients with patient-reported outcomes: the University of California, San Francisco, Gender Quality of Life Survey. Plast Reconstr Surg. 2021;147(5):731e\u201340e. https:\/\/doi.org\/10.1097\/PRS.0000000000007883.","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"15701_CR68","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/PRS.0b013e3181aee807","volume":"124","author":"AL Pusic","year":"2009","unstructured":"Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;124(2):345\u201353. https:\/\/doi.org\/10.1097\/PRS.0b013e3181aee807.","journal-title":"Plast Reconstr Surg"},{"issue":"10","key":"15701_CR69","doi-asserted-by":"publisher","first-page":"e025435","DOI":"10.1136\/bmjopen-2018-025435","volume":"8","author":"AF Klassen","year":"2018","unstructured":"Klassen AF, Kaur M, Johnson N, et al. International phase I study protocol to develop a patient-reported outcome measure for adolescents and adults receiving gender-affirming treatments (the GENDER-Q). BMJ Open. 2018;8(10):e025435. https:\/\/doi.org\/10.1136\/bmjopen-2018-025435.","journal-title":"BMJ Open"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15701-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15701-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15701-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T12:02:58Z","timestamp":1728043378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15701-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["15701"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15701-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no disclosures to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}